Filter
383
Filtered Results: 383
Text search:
Marburg
Featured
Recommendations
61
New Publications
100
Language
Document type
No document type
247
Guidelines
46
Studies & Reports
21
Fact sheets
21
Manuals
14
Training Material
11
Situation Updates
8
Strategic & Response Plan
6
Brochures
3
Resource Platforms
3
App
1
Infographics
1
Online Courses
1
Countries / Regions
Liberia
34
Sierra Leone
33
Guinea
31
Germany
30
Congo, Democratic Republic of
28
Burkina Faso
21
Nigeria
20
Uganda
19
Mali
18
Rwanda
17
Senegal
17
Côte d’Ivoire / Ivory Coast
15
Global
13
Ghana
9
West and Central Africa
9
Niger
7
Chad
7
Western and Central Europe
6
Africa
5
Tanzania
5
Cameroon
4
Guinea-Bissau
4
India
4
Togo
3
Middle East and North Africa
3
East and Southern Africa
3
Ethiopia
3
Kenya
2
Philippines
2
Saudi Arabia
2
South Africa
2
South Sudan
2
Indonesia
2
Ecuador
2
Nepal
1
Benin
1
Syria
1
Peru
1
Morocco
1
Latin America and the Carribbean
1
Bolivia
1
Bangladesh
1
Russia
1
Yemen
1
Central African Republic
1
Angola
1
Authors & Publishers
Publication Years
Category
Countries
67
Clinical Guidelines
32
Key Resources
30
Public Health
8
Capacity Building
6
Women & Child Health
5
Pharmacy & Technologies
4
Toolboxes
Ebola & Marburg
170
Rapid Response
56
Refugee
27
COVID-19
19
Pharmacy
13
Planetary Health
10
Health Financing Toolbox
9
Global Health Education
9
Mental Health
7
Specific Hazards
7
Caregiver
7
NTDs
6
AMR
5
TB
4
Polio
2
Natural Hazards
1
HIV
1
Social Ethics
1
Conflict
1
Les infections associées aux soins (IAS) touchent des centaines de millions de patients dans le monde chaque année. Ces infections sont à l’origine de pathologies graves, de prolongements de la durée du séjour en établissement de soins, d’invalidités à long terme, de coûts personnels im...
A global Review of evidence and practice
This briefing note is based on the existing WHO and ILO guides and recommendations for Ebola Virus
Disease at the time of the publication. It will be updated as new information and recommendations become
available.
Practical guidance on immunization services and the risks they present for both Ebola affected and non-affected countries. The specific purpose of this document is to assist countries to:
- Maintain immunization services and use immunization contacts and surveillance system as opportunities to ...
mBio, Vol. 6 Issue 2, March/April 2015
Available evidence demonstrates that direct patient contact and contact with infectious body fluids are the primary modes for Ebola virus transmission, but this is based on a limited number of studies. In this review, the authors address what we know and what ...
The Government of India is embarking on a mammoth task to prevent COVID-19 spread among communities. The Rapid Evidence Synthesis team received a request to support the planning and development of resources for ensuring preparedness of FLHWs for COVID-19 . The rapid evidence synthesis was conducted ...
MMWR Morbidity and Mortality Weekly Report December 19, 2014 / 63(50);1205-1206
Report of the WHO/Bill & Melinda Gates Foundation Consultation. The Consultation was organized back-to-back with the first annual meeting of the International Coordinating Group of the BMGF-funded project for human and dog rabies elimination in developing countries, held at WHO headquarters, Geneva,...
Preparedness planning is essential in order to respond effectively to outbreaks, including single case occurrences of highconsequence infectious diseases (HCID), such as the importation of a viral haemorrhagic fever (VHF) case
A review of current literature and up date data from the field, April 2015.
This report has been published in part in J Hosp Inf. 2015;90:1-9.
http://www.ncbi.nlm.nih.gov/pubmed/?term=ebola+nosocomial+shears
Responses to epidemics, emergencies and disasters raise many ethical issues for the people involved, including public health specialists and policy makers. This training manual provides material on ethical issues in research, surveillance and patient care in these difficult contexts.
Traitements contre la maladie à virus Ebola
recommended
Cette première version des orientations evolutives relatives a la prise en charge clinique de la MVE contient quatre nouvelles recommandations concernant l’utilisation de traitements contre la MVE, y compris deux recommandations fortes en faveur de l’utilisation de thérapies à base d’antico...
